Literature DB >> 24909400

Negative impact of laws regarding biosecurity and bioterrorism on real diseases.

N Wurtz1, M P Grobusch, D Raoult.   

Abstract

Research on highly pathogenic microorganisms in biosafety level 3 and 4 laboratories is very important for human public health, as it provides opportunities for the development of vaccines and novel therapeutics as well as diagnostic methods to prevent epidemics. However, in recent years, after the anthrax and World Trade Center attacks in 2001 in the USA, the threat of bioterrorism has grown for both the public and the authorities. As a result, technical and physical containment measures and biosafety and biosecurity practices have been implemented in laboratories handling these dangerous pathogens. Working with selected biological agents and toxins is now highly regulated, owing to their potential to pose a threat to public health and safety, despite the fact that the anthrax attack was found to be the result of a lack of security at a US Army laboratory. Thus, these added regulations have been associated with a large amount of fruitless investment. Herein, we describe the limitations of research in these facilities, and the multiple consequences of the increased regulations. These limitations have seriously negatively impacted on the number of collaborations, the size of research projects, and, more generally, scientific research on microbial pathogens. Clearly, the actual number of known victims and fatalities caused by the intentional use of microorganisms has been negligible as compared with those caused by naturally acquired human infections.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Biosafety; biosafety laboratory; biosecurity; bioterrorism; infectious disease; laws; limitations; regulations; select agent and toxins

Mesh:

Substances:

Year:  2014        PMID: 24909400     DOI: 10.1111/1469-0691.12709

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Authors:  N Wurtz; A Papa; M Hukic; A Di Caro; I Leparc-Goffart; E Leroy; M P Landini; Z Sekeyova; J S Dumler; D Bădescu; N Busquets; A Calistri; C Parolin; G Palù; I Christova; M Maurin; B La Scola; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-27       Impact factor: 3.267

2.  International Biological Reference Preparations for Epidemic Infectious Diseases.

Authors:  Tommy Rampling; Mark Page; Peter Horby
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

Review 3.  Laboratory-acquired Scrub Typhus and Murine Typhus Infections: The Argument for a Risk-based Approach to Biosafety Requirements for Orientia tsutsugamushi and Rickettsia typhi Laboratory Activities.

Authors:  Stuart D Blacksell; Matthew T Robinson; Paul N Newton; Nicholas P J Day
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.